[1]ACSMedicinalChemistryLetters,2011,vol.2,#12,p.907-912
[1]ACSMedicinalChemistryLetters,2011,vol.2,p.907-912
[1]Patent:WO2019/195753,2019,A1.Locationinpatent:Page/Pagecolumn162;164
[1]Patent:WO2019/195753,2019,A1.Locationinpatent:Page/Pagecolumn193-194
[1]CurrentPatentAssignee:SumitomoChemical(w/oDongwooFine-Chem);SumitomoPharma(in:SumitomoChemical);SUMITOMOCHEMICALCOMPANYLIMITED-WO2021/67772,2021,A1
Title: Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20150501
Title: Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.
Journal: ACS medicinal chemistry letters 20111208
Title: Chemistry of tobacco constituents. Oxidation of alpha-ionone and the acid-catalyzed rearrangement of 5-keto-alpha-ionone.
Journal: Journal of agricultural and food chemistry 19760101
Title: Mollard A, et al. Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors. ACS Med Chem Lett. 2011 Dec 8;2(12):907-912.